NCT00093730View on ClinicalTrials.gov

BMS-599626 in Treating Patients With Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

BMS-59926

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00093730 - BMS-599626 in Treating Patients With Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter